Cys-McMMAF
(2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[6-[3-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]hexanoyl-methylamino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoyl]amino]-3-phenylpropanoic acid
Molecular Identity
Cys-McMMAF
(2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[6-[3-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]hexanoyl-methylamino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoyl]amino]-3-phenylpropanoic acid
PubChem CID: 86278355
2D Structure
Properties
C52H83N7O13S
Molecular Formula
1046.30
Molecular Weight
g/mol
1045.5770
Exact Mass
Da
1.4
XLogP
Drug-like (Lipinski: < 5)
301
TPSA
May have limited oral absorption
5
H-Bond Donors
15
H-Bond Acceptors
1880
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Cys-McMMAF1160590-05-5Denintuzumab mafodotinVorsetuzumab mafodotinSGN-CD19ASGN-CD 19AUNII-H5324S1M7HDenintuzumab mafodotin [USAN:INN]H5324S1M7H1165741-01-41399672-02-6Immunoglobulin G1-kappa auristatin F conjugate, anti-(homosapiens CD19 (b lymphocyte surface antigen B4, leu-12)), humanized monoclonal antibodyVorsetzumab MafodotinVorsetzumab Mafodotin [USAN]UNII-699619YVTQ
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Cys-McMMAF
Loading drug network...